MOHAMMAD AZAB - 09 Jan 2023 Form 4 Insider Report for LISATA THERAPEUTICS, INC. (LSTA)

Role
Director
Signature
James Nisco, Attorney-in-Fact for Mohammad Azab
Issuer symbol
LSTA
Transactions as of
09 Jan 2023
Net transactions value
$0
Form type
4
Filing time
11 Jan 2023, 15:12:19 UTC
Previous filing
13 Dec 2022
Next filing
02 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LSTA Common Stock Award $0 +20,000 +104% $0.000000 39,200 09 Jan 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 20,000 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 9, 2024.
F2 Includes 39,200 unvested restricted stock units.